Bilimsel çalışmalar

Prof. Dr. Erkan Doğan

49 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Adem Yokuş, Harun Arslan, Zülküf Akdemir, İbrahim Akbudak, Necat Almalı, Çetin Kotan, Erkan Doğan. Measurement of Postoperative Liver Volume Changes In Patients With Gastric Cancer By Computed Tomography. East J Med 28(2):206-210, 2023. DOI:10.5505/ejm.2023.12129

    Kaynak: medicana.com.tr profil sayfası

  2. Aycan A, Celik S, Kuyumcu F, Akyol ME, Arslan M, Dogan E, Arslan H. Spinal Metastasis of Unknown Primary Accompanied by Neurologic Deficit or Vertebral Instability. World Neurosurg. 2018 Jan;109:e33-e42. doi:10.1016/j.wneu.2017.09.099

    Kaynak: medicana.com.tr profil sayfası

  3. Arslan H, Fatih Özbay M, Çallı İ, Doğan E, Çelik S, Batur A, Bora A, Yavuz A, Bulut MD, Özgökçe M, Çetin Kotan M. Contribution of diffusion weighted MRI to diagnosis and staging in gastric tumors and comparison with multi-detector computed tomography. Radiol Oncol. 2017;51(1):23-29

    Kaynak: medicana.com.tr profil sayfası

  4. Sunnetcioglu A, Arısoy A, Demir Y, Ekin S, Dogan E. Associations between the standardized uptake value of 18F-FDG PET/CT and demographic, clinical, pathological, radiological factors in lung cancer. Int J Clin Exp Med. 2015;8(9):15794-800

    Kaynak: medicana.com.tr profil sayfası

  5. Turan N, Benekli M, Unal OU, Unek İT, Tastekin D ve ark. Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma. Chin J Cancer Res. 2015;27(4):408-16

    Kaynak: medicana.com.tr profil sayfası

  6. Can A, Dogan E, Bayoglu IV ve ark. Multicenter epidemiologic study on hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev. 2014;15(6):2923-7

    Kaynak: medicana.com.tr profil sayfası

  7. Turan N, Benekli M, Dane F ve ark. Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer. Thorac Cancer. 2014;5(5):398-404

    Kaynak: medicana.com.tr profil sayfası

  8. Koca D, Dogan E, Yardim H ve ark. A modified DCF regimen as primary treatment for patients with metastatic gastric cancer. J BUON. 2013;18(2):377-84

    Kaynak: medicana.com.tr profil sayfası

  9. Dogan E, Yorgun H, Petekkaya I ve ark. Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. Med Oncol. 2012

    Kaynak: medicana.com.tr profil sayfası

  10. Dogan E, Yalcin S, Koca D, Olmez A. Clinicopathological characteristics of hepatocellular carcinoma in Turkey. Asian Pac J Cancer Prev. 2012;13:2985-90

    Kaynak: medicana.com.tr profil sayfası

  11. Arslan C, Ozdemir E, Dogan E, Ozisik Y, Altundag K. Secondary hematological malignancies after treatment of non-metastatic breast cancer. J BUON. 2011;16:744-50

    Kaynak: medicana.com.tr profil sayfası

  12. Dogan E, Aksoy S, Dizdar O ve ark. Pure mucinous carcinoma of the breast: a single center experience. J BUON. 2011;16:565-7

    Kaynak: medicana.com.tr profil sayfası

  13. Bulut N, Aksoy S, Dizdar O ve ark. Demographic and clinico-pathological characteristics in patients with triple-negative and non-triple-negative breast cancer. Med Oncol. 2011;28:S75-9

    Kaynak: medicana.com.tr profil sayfası

  14. Turgut D, Kalan I, Dede DS, Dogan E, Altundag K. Ipsilateral axillary recurrence of breast cancer 22 years after primary surgery: the latest recurrence in the literature. J BUON. 2011;16:571

    Kaynak: medicana.com.tr profil sayfası

  15. Kara O, Ozdemir E, Arslan C, Dogan E, Altundag K. Acute promyelocytic leukemia in a young patient with breast cancer. Med Oncol. 2011;28:249-50

    Kaynak: medicana.com.tr profil sayfası

  16. Z. Arik, E. Dogan, S. Aksoy, K. Altundag. Long-term survivors among breast cancer patients with brain metastases. Ann Oncol. 2010;21:1128

    Kaynak: medicana.com.tr profil sayfası

  17. E. Dogan, S. Aksoy, O. Dizdar, D.S. Dede, C. Arslan, Y. Ozisik, K. Altundag. Other malignancies in patients with breast cancer: a single institute experience. Med Oncol. 2010 Dec;27(4):1434-1435

    Kaynak: medicana.com.tr profil sayfası

  18. E. Dogan, S. Aksoy, C. Arslan, D.S. Dede, K. Altundag. Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma. Med Oncol. 2010;27:1436-1437

    Kaynak: medicana.com.tr profil sayfası

  19. E. Altan, C. Arslan, D. Dede, E. Dogan, K. Altundag. Primary angiosarcoma of the breast after pregnancy. Am Surg. 2010;76:E115

    Kaynak: medicana.com.tr profil sayfası

  20. N. Kertmen, E. Dogan, K. Altundag. Pure mucinous breast carcinoma with lung metastasis in a young male patient. Am Surg. 2010;76:E146

    Kaynak: medicana.com.tr profil sayfası

  21. D. Sarikaya, O. Varan, G. Ozen, E. Dogan, K. Altundag. Late recurrence of granulosa cell tumor of the ovary with synchronous gastric signet-ring cell carcinoma. J BUON. 2010;15:799-800

    Kaynak: medicana.com.tr profil sayfası

  22. O. Varan, G. Ozen, D. Sarikaya, E. Dogan, K. Altundag. Malignant hypercalcemia in a patient with maxillary sinus squamous cell carcinoma without skeletal metastases. Am Surg. 2010;76:E9-10

    Kaynak: medicana.com.tr profil sayfası

  23. E. Altan, B. Bitik, Y. Kalpakci, E. Dogan, K. Altundag. Probable hepatotoxicity related to Nerium oleander extract in a patient with metastatic synovial sarcoma of the knee. J Altern Complement Med. 2009;15:113

    Kaynak: medicana.com.tr profil sayfası

  24. B. Bitik, Y. Kalpakci, E. Altan, E. Dogan, K. Altundag. Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel-cisplatin-5-fluorouracil regimen. Ann Oncol. 2009;20:394-395

    Kaynak: medicana.com.tr profil sayfası

  25. E. Dogan, R. Ozgur, V. Ercan, A. Tekin, O. Senkal, U. Cevikbas. Nodular regenerative hyperplasia of the liver: a case report. Turkish Journal of Gastroenterology. 2003;14:64

    Kaynak: medicana.com.tr profil sayfası

  26. E. Dogan, H. Yorgun, I. Petekkaya, N. Ozer, K. Altundag, Y. Ozisik. Evaluation of cardiac safety of lapatinib therapy for ErbB2-positive metastatic breast cancer: A single center experience. 2011 ASCO Annual Meeting, April 2011, Chicago, USA. Sözel Bildiri

    Kaynak: medicana.com.tr profil sayfası

  27. O. Keskin, C. Arslan, O. Dizdar, S. Aksoy, E. Dogan, D.S. Dede, I.H. Gullu, Y.Y. Ozisik, K. Altundag. Relation of tumor localization and metastasis sites in patients with breast cancer. ASCO 2011, Chicago, USA

    Kaynak: medicana.com.tr profil sayfası

  28. D.S. Dede, C. Arslan, S. Aksoy, O. Dizdar, E. Dogan, A. Alkan, I.H. Gullu, Y.Y. Ozisik, K. Altundag. Clinicopathologic features of patients with breast cancer under treatment of bisphosphonate at the time of diagnosis: Retrospective analysis. ASCO 2011, Chicago, USA

    Kaynak: medicana.com.tr profil sayfası

  29. I. Petekkaya, C. Arslan, E. Dogan, M. Solak, O. Keskin, N. Kertmen, Y.Y. Ozisik, K. Altundag. Body mass index in breast cancer subtypes. ASCO 2011, Chicago, USA

    Kaynak: medicana.com.tr profil sayfası

  30. M. Solak, F.P. Turkoz, I. Petekkaya, C. Arslan, N. Kertmen, O. Keskin, E. Dogan, Y.Y. Ozisik, M.K. Altundag. Association between blood groups and breast cancer subtype. ASCO 2011, Chicago, USA

    Kaynak: medicana.com.tr profil sayfası

  31. M. Ozen, S. Aksoy, O. Dizdar, D.S. Dede, E. Dogan, C. Arslan, I.H. Gullu, M.K. Altundag. Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis. ASCO 2010, Chicago, USA

    Kaynak: medicana.com.tr profil sayfası

  32. Z.G. Sürmeli, S. Aksoy, O. Dizdar, D.S. Dede, E. Dogan, C. Arslan, I.H. Gullu, K. Altundag. Docetaxel/doxorubicin/cyclophosphamide chemotherapy for operable HER2-negative, node-positive breast cancer patients: Results from a single institution. ASCO 2010, Chicago, USA

    Kaynak: medicana.com.tr profil sayfası

  33. S. Aksoy, C. Arslan, M. Kurt, O. Dizdar, D.S. Dede, E. Dogan, I.H. Gullu, Y.Y. Ozisik, M.K. Guler. Increased mean corpuscular volume of erythrocytes with capecitabine treatment in metastatic breast cancer patients: A marker of clinical benefit. ASCO 2010, Chicago, USA

    Kaynak: medicana.com.tr profil sayfası

  34. C. Arslan, O. Dizdar, D.S. Dede, M. Isik, E. Dogan, Y.Y. Ozisik, K. Altundag. Clinicopathological features of locally advanced HER2-negative breast cancer patients with stage N3 disease. ASCO 2011, Chicago, USA

    Kaynak: medicana.com.tr profil sayfası

  35. S. Aksoy, N. Bulut, O. Dizdar, D. Dede, C. Arslan, E. Dogan, Y. Ozisik, K. Altundag. Demographic, clinical and pathological characteristics of very young breast cancer patients younger than 30 years in Turkish population. 5th International APOCP Conference, 2010, Istanbul, Turkey

    Kaynak: medicana.com.tr profil sayfası

  36. A. Can, E. Dogan, I.V. Bayoglu, A.M. Tatli, M. Besiroglu, M. Kocer, U. Uyetürk, D. Kivrak, Z. Orakci, O. Bal, T. Kacan, N. Turan. Epidemiology of Hepatocellular Carcinoma in Turkey: Outcome of a Multicenter Study. 3rd International Gastrointestinal Cancer Conference, December 13-15, 2013, Antalya, Turkey

    Kaynak: medicana.com.tr profil sayfası

  37. E. Dogan, A. Can, M.F. Ozbay, H. Arslan, G. Yilmazer, D. Koca, C. Kotan. Clinicopathological Characteristics of Esophageal Cancer Patients of Van Region. 3rd International Gastrointestinal Cancer Conference, December 13-15, 2013, Antalya, Turkey

    Kaynak: medicana.com.tr profil sayfası

  38. H. Arslan, M.F. Ozbay, I. Calli, E. Dogan. Comparison of Diffusion Weighted MR Imaging with Multidetector CT Imaging in the Diagnosis of Gastric Tumors. 3rd International Gastrointestinal Cancer Conference, December 13-15, 2013, Antalya, Turkey

    Kaynak: medicana.com.tr profil sayfası

  39. E. Dogan, H. Guducuoglu, A. Can, R. Erten, S. Koc, Y. Bayram. Human Papilloma Virus and Survival of Patients with Esophageal Squamous Cell Cancers. 3rd International Gastrointestinal Cancer Conference, December 13-15, 2013, Antalya, Turkey

    Kaynak: medicana.com.tr profil sayfası

  40. H.G. Sahin, G. Guvendi, H.A. Sahin, D. Kusaslan Avci, E. Dogan. Violence among Cancer Patients in Eastern Turkey. World Congress of Internal Medicine, October 25-29, 2014, Seoul, Korea. Oral Presentation

    Kaynak: medicana.com.tr profil sayfası

  41. E. Dogan, A. Can. Comparison of palliative chemotherapy using cisplatin and fluorouracil with docetaxel, cisplatin and fluorouracil combination regimens in patients with metastatic esophageal cancer. 4th International Gastrointestinal Cancer Conference, December 2014. Oral Presentation

    Kaynak: medicana.com.tr profil sayfası

  42. S. Celik, E. Dogan, H. Arslan, A. Batur, R. Kiziltan, O. Toktas, O. Yilmaz, M.C. Kotan. Changing Trends and Experience with Esophageal Cancer Surgery in a Single University Hospital: Are the Results Similar or Not. Bagcilar Medical Bulletin. 2017;2(1):1-8

    Kaynak: medicana.com.tr profil sayfası

  43. E. Dogan. Nonseminomatous Testicular Cancer. Turkiye Klinikleri Journal of Medical Oncology. 2015

    Kaynak: medicana.com.tr profil sayfası

  44. G. Ugurluer, E. Dogan, N. Turan. Cutaneous Metastases from Transitional Cell Carcinoma of the Bladder in a Case with Two Primaries. Erciyes Medical Journal. 2010

    Kaynak: medicana.com.tr profil sayfası

  45. E. Dogan, S. Kilickap, I. Celik. New Drugs Used in Chemoprevention. Review. Turkiye Klinikleri Journal of Medical Oncology Special Topics. 2009;73-82

    Kaynak: medicana.com.tr profil sayfası

  46. A. Surardamar, T. Yakar, N. Usalan, E. Dogan, M.F. Akdogan, O. Yapici. Conn’s Syndrome: Case Report. Haydarpasa Numune Training and Research Hospital Medical Journal. 2003;115-118

    Kaynak: medicana.com.tr profil sayfası

  47. E. Hur, N.Y. Bagatur, E. Ahishali, E. Dogan, O. Mavis. Comparison of Treatment Efficacy of Two-Week Lansoprazole plus One- and Two-Week Clarithromycin Combinations in Helicobacter Pylori Eradication. Taksim Training and Research Hospital Medical Journal. 2002;32:7-12

    Kaynak: medicana.com.tr profil sayfası

  48. E. Hur, O. Mavis, E. Dogan, F. Akvardar, R. Ozgur, V. Ercan. Monoclonal Gammopathy of Undetermined Significance: A Case Report. Taksim Training and Research Hospital Medical Journal. 2002;32:13-16

    Kaynak: medicana.com.tr profil sayfası

  49. E. Dogan, I. Ekizoglu, E. Hur, O. Mavis, V. Ercan, A. Tekin. Phenytoin-Induced Osteomalacia: A Case Report. Taksim Training and Research Hospital Medical Journal. 2002;32:20-22

    Kaynak: medicana.com.tr profil sayfası